ZD1839, a novel, oral epidermal growth factor...

Lung Cancer 2003 / 6 Vol. 40; Iss. 3

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

Pallis, A.G., Mavroudis, D., Androulakis, N., Souglakos, J., Kouroussis, C., Bozionelou, V., Vlachonikolis, I.G., Georgoulias, V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
40
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)00079-5
Date:
June, 2003
File:
PDF, 195 KB
english, 2003
Conversion to is in progress
Conversion to is failed